Cargando…

2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission

BACKGROUND: Measles is a highly contagious disease and nosocomial outbreaks have been documented. Pediatric hospitals are particularly at risk due to the concentration of susceptible patients such as infants <12 months old or with immunocompromised status. Effective strategies to control nosocomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seah, Valerie Xue Fen, Chong, Chia Yin, Tan, Natalie Woon Hui, Thoon, Koh Cheng, Yung, Chee Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254096/
http://dx.doi.org/10.1093/ofid/ofy210.1843
_version_ 1783373645314260992
author Seah, Valerie Xue Fen
Chong, Chia Yin
Tan, Natalie Woon Hui
Thoon, Koh Cheng
Yung, Chee Fu
author_facet Seah, Valerie Xue Fen
Chong, Chia Yin
Tan, Natalie Woon Hui
Thoon, Koh Cheng
Yung, Chee Fu
author_sort Seah, Valerie Xue Fen
collection PubMed
description BACKGROUND: Measles is a highly contagious disease and nosocomial outbreaks have been documented. Pediatric hospitals are particularly at risk due to the concentration of susceptible patients such as infants <12 months old or with immunocompromised status. Effective strategies to control nosocomial measles transmission will be critical for successful measles elimination. We reviewed the impact of our hospital’s approach for post-exposure prophylaxis (PEP) against measles. METHODS: We extracted details of all measles intra-hospital exposure events in our pediatric hospital in April 2016 to December 2016. For this analysis, we only included close contacts who were defined as patients within the same cubicle as the measles index case for any duration prior to the index case isolation. All close contacts were followed up with a telephone call to check if they developed fever or rash after the incubation period. In May 2016, we implemented measles PEP [(measles, mumps, and rubella (MMR) vaccine or immune globulin (IG)) for close contacts in accordance to their age and immunity status. Details of events pre-vs. post-PEP implementation were analysed. RESULTS: Prior to PEP implementation, there were two exposure events resulting in eight close contacts, of which seven (87.5%) had no MMR vaccination and one had received a single dose. Subsequently, two (25%) developed confirmed measles approximately 2 weeks post-exposure. Post-PEP implementation, there were four exposure events resulting in 14 close contacts, of which all had no MMR vaccination. Five patients were positive for measles serology. Measles PEP was given to eight patients, where seven received IG and one (7.1%) had MMR vaccination. At follow-up, two of the 14 close contacts reported fever during the incubation period but none developed measles. One was already known to be measles serology positive and the second who was given IG was diagnosed with unresolved RSV. CONCLUSION: Implementation of measles PEP in our hospital prevented secondary nosocomial transmission amongst susceptible close contacts in the same cubicle. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254096
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62540962018-11-28 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission Seah, Valerie Xue Fen Chong, Chia Yin Tan, Natalie Woon Hui Thoon, Koh Cheng Yung, Chee Fu Open Forum Infect Dis Abstracts BACKGROUND: Measles is a highly contagious disease and nosocomial outbreaks have been documented. Pediatric hospitals are particularly at risk due to the concentration of susceptible patients such as infants <12 months old or with immunocompromised status. Effective strategies to control nosocomial measles transmission will be critical for successful measles elimination. We reviewed the impact of our hospital’s approach for post-exposure prophylaxis (PEP) against measles. METHODS: We extracted details of all measles intra-hospital exposure events in our pediatric hospital in April 2016 to December 2016. For this analysis, we only included close contacts who were defined as patients within the same cubicle as the measles index case for any duration prior to the index case isolation. All close contacts were followed up with a telephone call to check if they developed fever or rash after the incubation period. In May 2016, we implemented measles PEP [(measles, mumps, and rubella (MMR) vaccine or immune globulin (IG)) for close contacts in accordance to their age and immunity status. Details of events pre-vs. post-PEP implementation were analysed. RESULTS: Prior to PEP implementation, there were two exposure events resulting in eight close contacts, of which seven (87.5%) had no MMR vaccination and one had received a single dose. Subsequently, two (25%) developed confirmed measles approximately 2 weeks post-exposure. Post-PEP implementation, there were four exposure events resulting in 14 close contacts, of which all had no MMR vaccination. Five patients were positive for measles serology. Measles PEP was given to eight patients, where seven received IG and one (7.1%) had MMR vaccination. At follow-up, two of the 14 close contacts reported fever during the incubation period but none developed measles. One was already known to be measles serology positive and the second who was given IG was diagnosed with unresolved RSV. CONCLUSION: Implementation of measles PEP in our hospital prevented secondary nosocomial transmission amongst susceptible close contacts in the same cubicle. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254096/ http://dx.doi.org/10.1093/ofid/ofy210.1843 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Seah, Valerie Xue Fen
Chong, Chia Yin
Tan, Natalie Woon Hui
Thoon, Koh Cheng
Yung, Chee Fu
2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title_full 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title_fullStr 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title_full_unstemmed 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title_short 2188. Effectiveness of a Risk-Stratified Measles Post-Exposure Prophylaxis Strategy to Prevent Nosocomial Transmission
title_sort 2188. effectiveness of a risk-stratified measles post-exposure prophylaxis strategy to prevent nosocomial transmission
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254096/
http://dx.doi.org/10.1093/ofid/ofy210.1843
work_keys_str_mv AT seahvaleriexuefen 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission
AT 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission
AT chongchiayin 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission
AT tannataliewoonhui 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission
AT thoonkohcheng 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission
AT yungcheefu 2188effectivenessofariskstratifiedmeaslespostexposureprophylaxisstrategytopreventnosocomialtransmission